Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 29.
doi: 10.1007/s11302-024-09996-9. Online ahead of print.

P2X7 receptors: a bibliometric review from 2002 to 2023

Haiting Tang  1 , Wei Wei  1 , Yu Luo  1 , Xiaoqing Lu  1 , Jun Chen  1 , Shenqiao Yang  1 , Fei Wu  2 , Haiyan Zhou  3 , Wenbin Ma  1 , Xin Yang  4
Affiliations
Review

P2X7 receptors: a bibliometric review from 2002 to 2023

Haiting Tang et al. Purinergic Signal. .

Abstract

For many years, there has been ongoing research on the P2X7 receptor (P2X7R). A comprehensive, systematic, and objective evaluation of the scientific output and status of P2X7R will be instrumental in guiding future research directions. This study aims to present the status and trends of P2X7R research from 2002 to 2023. Publications related to P2X7R were retrieved from the Web of Science Core Collection database. Quantitative analysis and visualization tools were Microsoft Excel, VOSviewer, and CiteSpace software. The analysis content included publication trends, literature co-citation, and keywords. 3282 records were included in total, with the majority of papers published within the last 10 years. Based on literature co-citation and keyword analysis, neuroinflammation, neuropathic pain, gastrointestinal diseases, tumor microenvironment, rheumatoid arthritis, age-related macular degeneration, and P2X7R antagonists were considered to be the hotspots and frontiers of P2X7R research. Researchers will get a more intuitive understanding of the status and trends of P2X7R research from this study.

Keywords: Bibliometrics; CiteSpace; P2X7 receptors; VOSviewer; Visualization.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 Receptor in Infection and Inflammation. Immunity 47:15–31. https://doi.org/10.1016/j.immuni.2017.06.020 - DOI - PubMed
    1. Burnstock G, Knight GE (2018) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. Purinergic Signal 14:1–18. https://doi.org/10.1007/s11302-017-9593-0 - DOI - PubMed
    1. Illes P, Mueller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ et al (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178:489–514. https://doi.org/10.1111/bph.15299 - DOI - PubMed
    1. Csoka B, Nemeth ZH, Toero G, Idzko M, Zech A, Koscso B et al (2015) Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. FASEB J 29:3626–3637. https://doi.org/10.1096/fj.15-272450 - DOI - PubMed - PMC
    1. Karmakar M, Katsnelson MA, Dubyak GR, Pearlman E (2016) Neutrophil P2X<sub>7</sub> receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP. Nat Commun 7. https://doi.org/10.1038/ncomms10555

LinkOut - more resources